Blueprint Medicines (BPMC) PT Raised to $52 at Jefferies

May 4, 2017 8:24 AM

Jefferies raised its price target on Blueprint Medicines (NASDAQ: BPMC) to $52.00 (from $42.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found